{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:41:22Z","timestamp":1768560082234,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12020-012-9629-8","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T09:16:35Z","timestamp":1329729395000},"page":"450-457","source":"Crossref","is-referenced-by-count":83,"title":["Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome"],"prefix":"10.1007","volume":"41","author":[{"given":"J. P.","family":"Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"A.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"M.","family":"Severo","sequence":"additional","affiliation":[]},{"given":"A. C.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"C.","family":"Lopes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"9629_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2458-4-9","volume":"4","author":"D Conen","year":"2004","unstructured":"D. Conen, V. Wietlisbach, P. Bovet, C. Shamlaye, W. Riesen, F. Paccaud, M. Burnier, Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4, 9 (2004). doi: 10.1186\/1471-2458-4-9","journal-title":"BMC Public Health"},{"issue":"1","key":"9629_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","volume":"202","author":"AC Gagliardi","year":"2009","unstructured":"A.C. Gagliardi, M.H. Miname, R.D. Santos, Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202(1), 11\u201317 (2009). doi: 10.1016\/j.atherosclerosis.2008.05.022","journal-title":"Atherosclerosis"},{"issue":"1","key":"9629_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11739-007-0004-3","volume":"2","author":"T Montalcini","year":"2007","unstructured":"T. Montalcini, G. Gorgone, C. Gazzaruso, G. Sesti, F. Perticone, A. Pujia, Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Intern. Emerg. Med. 2(1), 19\u201323 (2007). doi: 10.1007\/s11739-007-0004-3","journal-title":"Intern. Emerg. Med."},{"issue":"4","key":"9629_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11739-008-0141-3","volume":"3","author":"T Nakagawa","year":"2008","unstructured":"T. Nakagawa, P. Cirillo, W. Sato, M. Gersch, Y. Sautin, C. Roncal, W. Mu, L.G. Sanchez-Lozada, R.J. Johnson, The conundrum of hyperuricemia, metabolic syndrome, and renal disease. Intern. Emerg. Med. 3(4), 313\u2013318 (2008). doi: 10.1007\/s11739-008-0141-3","journal-title":"Intern. Emerg. Med."},{"issue":"3","key":"9629_CR5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/oxfordjournals.aje.a117634","volume":"142","author":"J Lee","year":"1995","unstructured":"J. Lee, D. Sparrow, P.S. Vokonas, L. Landsberg, S.T. Weiss, Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am. J. Epidemiol. 142(3), 288\u2013294 (1995)","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"9629_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-007-9132-3","volume":"22","author":"W Rathmann","year":"2007","unstructured":"W. Rathmann, B. Haastert, A. Icks, G. Giani, J.M. Roseman, Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur. J. Epidemiol. 22(7), 439\u2013445 (2007). doi: 10.1007\/s10654-007-9132-3","journal-title":"Eur. J. Epidemiol."},{"issue":"17","key":"9629_CR7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"D.I. Feig, D.H. Kang, R.J. Johnson, Uric acid and cardiovascular risk. N. Engl. J. Med. 359(17), 1811\u20131821 (2008). doi: 10.1056\/NEJMra0800885","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"9629_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.HYP.0000150785.39055.e8","volume":"45","author":"RJ Johnson","year":"2005","unstructured":"R.J. Johnson, D.I. Feig, J. Herrera-Acosta, D.H. Kang, Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 45(1), 18\u201320 (2005). doi: 10.1161\/01.HYP.0000150785.39055.e8","journal-title":"Hypertension"},{"issue":"2","key":"9629_CR9","first-page":"92","volume":"19","author":"M Cigolini","year":"1995","unstructured":"M. Cigolini, G. Targher, M. Tonoli, F. Manara, M. Muggeo, G. De Sandre, Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women. Int. J. Obes. Relat. Metab. Disord. 19(2), 92\u201396 (1995)","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"2","key":"9629_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncpneph0019","volume":"1","author":"T Nakagawa","year":"2005","unstructured":"T. Nakagawa, K.R. Tuttle, R.A. Short, R.J. Johnson, Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1(2), 80\u201386 (2005). doi: 10.1038\/ncpneph0019","journal-title":"Nat Clin Pract Nephrol"},{"issue":"4","key":"9629_CR11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/01.HYP.0000091371.53502.D3","volume":"42","author":"K Masuo","year":"2003","unstructured":"K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, M.L. Tuck, Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 42(4), 474\u2013480 (2003)","journal-title":"Hypertension"},{"issue":"2","key":"9629_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc07-1276","volume":"31","author":"A Dehghan","year":"2008","unstructured":"A. Dehghan, M. van Hoek, E.J. Sijbrands, A. Hofman, J.C. Witteman, High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 31(2), 361\u2013362 (2008). doi: 10.2337\/dc07-1276","journal-title":"Diabetes Care"},{"issue":"1","key":"9629_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12020-011-9449-2","volume":"40","author":"T Wang","year":"2011","unstructured":"T. Wang, Y. Bi, M. Xu, Y. Huang, Y. Xu, X. Li, W. Wang, G. Ning, Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40(1), 109\u2013116 (2011). doi: 10.1007\/s12020-011-9449-2","journal-title":"Endocrine"},{"issue":"3","key":"9629_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1185\/030079904125002982","volume":"20","author":"M Alderman","year":"2004","unstructured":"M. Alderman, K.J. Aiyer, Uric acid: role in cardiovascular disease and effects of losartan. Curr. Med. Res. Opin. 20(3), 369\u2013379 (2004). doi: 10.1185\/030079904125002982","journal-title":"Curr. Med. Res. Opin."},{"issue":"32","key":"9629_CR15","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.2174\/138161205774913246","volume":"11","author":"M Schachter","year":"2005","unstructured":"M. Schachter, Uric acid and hypertension. Curr. Pharm. Des. 11(32), 4139\u20134143 (2005)","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"9629_CR16","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Y.Y. Sautin, T. Nakagawa, S. Zharikov, R.J. Johnson, Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol 293(2), C584\u2013C596 (2007). doi: 10.1152\/ajpcell.00600.2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"9629_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cmet.2007.01.005","volume":"5","author":"KJ Cheung","year":"2007","unstructured":"K.J. Cheung, I. Tzameli, P. Pissios, I. Rovira, O. Gavrilova, T. Ohtsubo, Z. Chen, T. Finkel, J.S. Flier, J.M. Friedman, Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab. 5(2), 115\u2013128 (2007). doi: 10.1016\/j.cmet.2007.01.005","journal-title":"Cell Metab."},{"issue":"3","key":"9629_CR18","doi-asserted-by":"crossref","first-page":"F625","DOI":"10.1152\/ajprenal.00140.2005","volume":"290","author":"T Nakagawa","year":"2006","unstructured":"T. Nakagawa, H. Hu, S. Zharikov, K.R. Tuttle, R.A. Short, O. Glushakova, X. Ouyang, D.I. Feig, E.R. Block, J. Herrera-Acosta, J.M. Patel, R.J. Johnson, A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290(3), F625\u2013F631 (2006). doi: 10.1152\/ajprenal.00140.2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"9629_CR19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/ard.2007.073601","volume":"67","author":"WY Lin","year":"2008","unstructured":"W.Y. Lin, C.S. Liu, T.C. Li, T. Lin, W. Chen, C.C. Chen, C.I. Li, C.C. Lin, In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study). Ann. Rheum. Dis. 67(3), 432\u2013433 (2008). doi: 10.1136\/ard.2007.073601","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"9629_CR20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.ATV.0000161274.87407.26","volume":"25","author":"N Ishizaka","year":"2005","unstructured":"N. Ishizaka, Y. Ishizaka, E. Toda, R. Nagai, M. Yamakado, Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler. Thromb. Vasc. Biol. 25(5), 1038\u20131044 (2005). doi: 10.1161\/01.ATV.0000161274.87407.26","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"9629_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2007.03.006","volume":"78","author":"T Wilsgaard","year":"2007","unstructured":"T. Wilsgaard, B.K. Jacobsen, Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979\u20132001. Diabetes Res. Clin. Pract. 78(2), 217\u2013224 (2007). doi: 10.1016\/j.diabres.2007.03.006","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"9629_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.annepidem.2006.10.001","volume":"17","author":"S Ryu","year":"2007","unstructured":"S. Ryu, J. Song, B.Y. Choi, S.J. Lee, W.S. Kim, Y. Chang, D.I. Kim, B.S. Suh, K.C. Sung, Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann. Epidemiol. 17(4), 245\u2013252 (2007). doi: 10.1016\/j.annepidem.2006.10.001","journal-title":"Ann. Epidemiol."},{"issue":"6","key":"9629_CR23","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00125-007-0651-y","volume":"50","author":"J Tong","year":"2007","unstructured":"J. Tong, E.J. Boyko, K.M. Utzschneider, M.J. McNeely, T. Hayashi, D.B. Carr, T.M. Wallace, S. Zraika, F. Gerchman, D.L. Leonetti, W.Y. Fujimoto, S.E. Kahn, Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans. Diabetologia 50(6), 1156\u20131160 (2007). doi: 10.1007\/s00125-007-0651-y","journal-title":"Diabetologia"},{"issue":"3","key":"9629_CR24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ypmed.2009.11.011","volume":"50","author":"AC Santos","year":"2010","unstructured":"A.C. Santos, M. Severo, H. Barros, Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev. Med. 50(3), 99\u2013105 (2010). doi: 10.1016\/j.ypmed.2009.11.011","journal-title":"Prev. Med."},{"issue":"6","key":"9629_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.annepidem.2003.09.013","volume":"14","author":"E Ramos","year":"2004","unstructured":"E. Ramos, C. Lopes, H. Barros, Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction. Ann. Epidemiol. 14(6), 437\u2013441 (2004). doi: 10.1016\/j.annepidem.2003.09.013","journal-title":"Ann. Epidemiol."},{"key":"9629_CR26","unstructured":"Organization, W.H.: Guidelines for ATC classification. Collaborating centre for drug statistics methodology. Nordic Council on Medicines. WHO. (1990)"},{"key":"9629_CR27","volume-title":"Rheumatology","author":"MC Horchberg","year":"2003","unstructured":"M.C. Horchberg, J.S. Smolen et al., Rheumatology, 3rd edn. (Mosby, New York, 2003)","edition":"3"},{"issue":"2","key":"9629_CR28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jada.2006.11.008","volume":"107","author":"C Lopes","year":"2007","unstructured":"C. Lopes, A. Aro, A. Azevedo, E. Ramos, H. Barros, Intake and adipose tissue composition of fatty acids and risk of myocardial infarction in a male Portuguese community sample. J. Am. Diet. Assoc. 107(2), 276\u2013286 (2007). doi: 10.1016\/j.jada.2006.11.008","journal-title":"J. Am. Diet. Assoc."},{"key":"9629_CR29","unstructured":"Lopes, C.: Reproducibility and validity of a semi-quantitative food frequency questionnaire. In Diet and acute myocardial infarction: a population based case-control study. PhD thesis. University of Porto, Porto, 79\u2013115 2000"},{"issue":"2","key":"9629_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/03014460903341836","volume":"37","author":"M Camoes","year":"2010","unstructured":"M. Camoes, M. Severo, A.C. Santos, H. Barros, C. Lopes, Testing an adaptation of the EPIC physical activity questionnaire in Portuguese adults: a validation study that assesses the seasonal bias of self-report. Ann. Hum. Biol. 37(2), 185\u2013197 (2010). doi: 10.3109\/03014460903341836","journal-title":"Ann. Hum. Biol."},{"issue":"17","key":"9629_CR31","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. Spertus, F. Costa, Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17), 2735\u20132752 (2005). doi: 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"issue":"16","key":"9629_CR32","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20131645 (2009). doi: 10.1161\/CIRCULATIONAHA.109.192644","journal-title":"Circulation"},{"issue":"8","key":"9629_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1631\/jzus.2007.B0593","volume":"8","author":"LY Chen","year":"2007","unstructured":"L.Y. Chen, W.H. Zhu, Z.W. Chen, H.L. Dai, J.J. Ren, J.H. Chen, L.Q. Chen, L.Z. Fang, Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 8(8), 593\u2013598 (2007). doi: 10.1631\/jzus.2007.B0593","journal-title":"J Zhejiang Univ Sci B"},{"issue":"4","key":"9629_CR34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1047-2797(97)00204-4","volume":"8","author":"W Rathmann","year":"1998","unstructured":"W. Rathmann, E. Funkhouser, A.R. Dyer, J.M. Roseman, Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann. Epidemiol. 8(4), 250\u2013261 (1998)","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"9629_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.78.1.25","volume":"78","author":"H Vuorinen-Markkola","year":"1994","unstructured":"H. Vuorinen-Markkola, H. Yki-Jarvinen, Hyperuricemia and insulin resistance. J. Clin. Endocrinol. Metab. 78(1), 25\u201329 (1994)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"9629_CR36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1006\/pmed.1996.0096","volume":"25","author":"C Russo","year":"1996","unstructured":"C. Russo, O. Olivieri, D. Girelli, P. Guarini, R. Corrocher, Relationships between serum uric acid and lipids in healthy subjects. Prev. Med. 25(5), 611\u2013616 (1996). doi: 10.1006\/pmed.1996.0096","journal-title":"Prev. Med."},{"issue":"5","key":"9629_CR37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.54.5.351","volume":"54","author":"Y Moriwaki","year":"1995","unstructured":"Y. Moriwaki, T. Yamamoto, S. Takahashi, Z. Tsutsumi, K. Higashino, Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia. Ann. Rheum. Dis. 54(5), 351\u2013354 (1995)","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"9629_CR38","first-page":"468","volume":"42","author":"F Cardona","year":"2003","unstructured":"F. Cardona, F.J. Tinahones, E. Collantes, A. Escudero, E. Garcia-Fuentes, F.J. Soriguer, The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology (Oxford) 42(3), 468\u2013472 (2003)","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"9629_CR39","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.ATV.17.9.1675","volume":"17","author":"JM Boer","year":"1997","unstructured":"J.M. Boer, C. Ehnholm, H.J. Menzel, L.M. Havekes, M. Rosseneu, D.S. O\u2019Reilly, L. Tiret, Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study. Arterioscler. Thromb. Vasc. Biol. 17(9), 1675\u20131681 (1997)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"9629_CR40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1536\/jhj.44.527","volume":"44","author":"A Bedir","year":"2003","unstructured":"A. Bedir, M. Topbas, F. Tanyeri, M. Alvur, N. Arik, Leptin might be a regulator of serum uric acid concentrations in humans. Jpn. Heart J. 44(4), 527\u2013536 (2003)","journal-title":"Jpn. Heart J."},{"issue":"1","key":"9629_CR41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1467-789x.2000.00008.x","volume":"1","author":"O Bosello","year":"2000","unstructured":"O. Bosello, M. Zamboni, Visceral obesity and metabolic syndrome. Obes. Rev. 1(1), 47\u201356 (2000)","journal-title":"Obes. Rev."},{"issue":"1","key":"9629_CR42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1681\/ASN.2006080865","volume":"18","author":"JP Forman","year":"2007","unstructured":"J.P. Forman, H. Choi, G.C. Curhan, Plasma uric acid level and risk for incident hypertension among men. J. Am. Soc. Nephrol. 18(1), 287\u2013292 (2007). doi: 10.1681\/ASN.2006080865","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"9629_CR43","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.HYP.0000249768.26560.66","volume":"48","author":"PB Mellen","year":"2006","unstructured":"P.B. Mellen, A.J. Bleyer, T.P. Erlinger, G.W. Evans, F.J. Nieto, L.E. Wagenknecht, M.R. Wofford, D.M. Herrington, Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension 48(6), 1037\u20131042 (2006). doi: 10.1161\/01.HYP.0000249768.26560.66","journal-title":"Hypertension"},{"issue":"12","key":"9629_CR44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.jhh.1002095","volume":"20","author":"A Shankar","year":"2006","unstructured":"A. Shankar, R. Klein, B.E. Klein, F.J. Nieto, The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J. Hum. Hypertens. 20(12), 937\u2013945 (2006). doi: 10.1038\/sj.jhh.1002095","journal-title":"J. Hum. Hypertens."},{"issue":"1","key":"9629_CR45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ije\/23.1.201","volume":"23","author":"J Lee","year":"1994","unstructured":"J. Lee, Odds ratio or relative risk for cross-sectional data? Int. J. Epidemiol. 23(1), 201\u2013203 (1994)","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"9629_CR46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/oem.52.7.494","volume":"52","author":"O Axelson","year":"1995","unstructured":"O. Axelson, M. Fredriksson, K. Ekberg, Use of the prevalence ratio v the prevalence odds ratio in view of confounding in cross sectional studies. Occup. Environ. Med. 52(7), 494 (1995)","journal-title":"Occup. Environ. Med."},{"issue":"10","key":"9629_CR47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1289\/ehp.6927","volume":"112","author":"P Neil","year":"2004","unstructured":"P. Neil, Effect measures in prevalence studies. Environ. Health Perspect. 112(10), 1047\u20131050 (2004)","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"9629_CR48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/oem.55.4.272","volume":"55","author":"ML Thompson","year":"1998","unstructured":"M.L. Thompson, J.E. Myers, D. Kriebel, Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup. Environ. Med. 55(4), 272\u2013277 (1998)","journal-title":"Occup. Environ. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9629-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9629-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9629-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:34Z","timestamp":1559440594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9629-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9629"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9629-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]}}}